CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
-22.93%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$539M
AUM Growth
+$539M
(-27%)
Cap. Flow
+$13M
Cap. Flow
% of AUM
2.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$13M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $248M | 45.93% |
16,245,817
+849,701
| +6% | +$13M |
|
2
Tenaya Therapeutics
TNYA
$184M
| $111M | 20.53% |
9,400,290
| – | – |
|
3
Revolution Medicines
RVMD
$7.1B
| $85.4M | 15.83% |
3,347,245
| – | – |
|
4
RAPT Therapeutics
RAPT
$188M
| $30.8M | 5.72% |
1,402,008
| – | – |
|
5
Surrozen
SRZN
$104M
| $28.3M | 5.25% |
9,414,795
| – | – |
|
6
Oric Pharmaceuticals
ORIC
$994M
| $19.1M | 3.53% |
3,568,181
| – | – |
|
|
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $17.3M | 3.2% |
4,309,329
| – | – |
|